TWI Biotechnology
TWD20.95
0
+TWD2.75+15.11% 06:59 Today
Statistics
Day High
22.05
Day Low
18.25
52W High
57.2
52W Low
12.85
Volume
1,950,077
Avg. Volume
1,433,282
Mkt Cap
4.31B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-202.37MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the development and sale of medications designed to address innate immunity disorders, primarily within Taiwan. The company's drug pipeline notably includes AC-203, which is currently undergoing Phase 2 clinical trials for various conditions such as epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus. Additionally, AC-1101 is in Phase 1 trials for vitiligo treatment and is advancing through preclinical stages for atopic dermatitis, granuloma annulare, and other uncommon autoimmune skin diseases. TWi Biotechnology has also established a drug development collaboration with Hong Kong Winhealth Pharma Group Co., Limited, targeting the markets of Mainland China, Hong Kong, and Macao. Founded in 2010, the company is headquartered in Taipei, Taiwan.
Show More
CEO
Chen-En Tsai
Employees
27
Country
Taiwan
ISIN
TW0006610009
Listings
0 Comments
Share your thoughts
FAQs
What is TWI Biotechnology stock price today?▼
The current price of 6610.TWO is TWD20.95 TWD — it has increased by +15.11% in the past 24 hours. Watch TWI Biotechnology stock price performance more closely on the chart.
What is TWI Biotechnology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange TWI Biotechnology stocks are traded under the ticker 6610.TWO.
Is TWI Biotechnology stock price growing?▼
6610.TWO stock has risen by +13.24% compared to the previous week, the month change is a -53.5% fall, over the last year TWI Biotechnology has showed a -38.92% decrease.
What is TWI Biotechnology market cap?▼
Today TWI Biotechnology has the market capitalization of 4.31B
What is TWI Biotechnology revenue for the last year?▼
TWI Biotechnology revenue for the last year amounts to 0 TWD.
What is TWI Biotechnology net income for the last year?▼
6610.TWO net income for the last year is -202.37M TWD.
How many employees does TWI Biotechnology have?▼
As of November 4, 2026, the company has 27 employees.
In which sector is TWI Biotechnology located?▼
TWI Biotechnology operates in the Health & Wellness sector.
When did TWI Biotechnology complete a stock split?▼
TWI Biotechnology has not had any recent stock splits.
Where is TWI Biotechnology headquartered?▼
TWI Biotechnology is headquartered in Taipei, Taiwan.